Epidemiology and pathologic features of Hodgkin lymphoma

International Journal of Hematology

Volumn 83, Issue 5, 2006, Pages 391-397

  Nakatsuka, Shin Ichi ^a   Aozasa, Katsuyuki ^b  

^a MINAMI OSAKA GENERAL HOSPITAL   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

B cells; Germinal center; Hodgkin lymphoma; Nodular lymphocyte predominant; Reed Sternberg cells

Indexed keywords

TRANSCRIPTION FACTOR;

AGE DISTRIBUTION; ARTICLE; B LYMPHOCYTE; CANCER CLASSIFICATION; CANCER EPIDEMIOLOGY; CANCER GENETICS; CANCER INCIDENCE; CLASSICAL HODGKIN LYMPHOMA; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DOWN REGULATION; ENVIRONMENTAL FACTOR; EPSTEIN BARR VIRUS; GERMINAL CENTER; HISTIOCYTE; HISTOPATHOLOGY; HODGKIN DISEASE; HUMAN; IMMUNOPHENOTYPING; LYMPHOCYTE; NODULAR LYMPHOCYTE PREDOMINANT HODGKIN LYMPHOMA; RACE DIFFERENCE; REED STERNBERG CELL; SEX DIFFERENCE; SOCIOECONOMICS; VIRUS CARCINOGENESIS; WORLD HEALTH ORGANIZATION;

B-LYMPHOCYTES; EPSTEIN-BARR VIRUS INFECTIONS; GERMINAL CENTER; HERPESVIRUS 4, HUMAN; HISTIOCYTES; HODGKIN DISEASE; HUMANS; ORGAN SPECIFICITY; REED-STERNBERG CELLS; TRANSCRIPTION FACTORS;

EID: 33749851451     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1532/IJH97.05184     Document Type: Article

References (36)

1. Stein H. Hodgkin lymphomas: introduction. In: Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. World Health Organization Classification of Tumours. Pathology & Genetics: Tumours of Haematopoietic and Lymphoid tissues. Lyon, France: IARC Press; 2001:237-239.
2. Perkins CI, Morris CR, Wright WE, Young JL Jr. Cancer Incidence and Mortality in California by Detailed Race/Ethnicity, 1988-1992. Sacramento, Calif: California Department of Health Services Surveillance Section; 1995.
3. Lambe M, Hsieh CC, Tsaih SW, Adami J, Glimelius B, Adami HO. Childbearing and the risk of Hodgkin's disease. Cancer Epidemiol Biomarkers Prev. 1998;7:831-834.
4. Hjalgrim H, Askling J, Pukkala E, Hansen S, Munksgaard L, Frisch M. Incidence of Hodgkin's disease in Nordic countries. Lancet. 2001;358:297-298.
5. Chen YT, Zheng T, Chou MC, Boyle P, Holford TR. The increase of Hodgkin's disease incidence among young adults: experience in Connecticut, 1935-1992. Cancer. 1997;79:2209-2218.
6. Cartwright R, Brincker H, Carli PM, et al. The rise in incidence of lymphomas in Europe 1985-1992. Eur J Cancer. 1999;35:627-633.
7. Macfarlane GJ, Evstifeeva T, Boyle P, Grufferman S. International patterns in the occurrence of Hodgkin's disease in children and young adult males. Int J Cancer. 1995;61:165-169.
8. Aozasa K, Ueda T, Tamai M, Tsujimura T. Hodgkin's disease in Osaka, Japan (1964-1985). Eur J Cancer Clin Oncol. 1986;22: 1117-1119.
9. Correa P, O'Conor GT. Epidemiological patterns of Hodgkin's disease. Int J Cancer. 1971;8:192-201.
10. Gutensohn N, Cole P. Epidemiology of Hodgkin's disease. Semin Oncol. 1980;7:92-102.
11. Kerzin-Storrar L, Faed MJ, MacGillivray JB, Smith PG. Incidence of familial Hodgkin's disease. Br J Cancer. 1983;47:707-712.
12. Mack TM, Cozen W, Shibata DK, et al. Concordance for Hodgkin's disease in identical twins suggesting genetic susceptibility to the young-adult form of the disease. N Engl J Med. 1995;332:413-418.
13. Hors J, Dausset J. HLA and susceptibility to Hodgkin's disease. Immunol Rev. 1983;70:167-192.
14. Harty LC, Lin AY, Goldstein AM, et al. HLA-DR, HLA-DQ, and TAP genes in familial Hodgkin disease. Blood. 2002;99:690-693.
15. Diepstra A, Niens M, Vellenga E, et al. Association with HLA class I in Epstein-Barr-virus-positive and with HLA class III in Epstein-Barr-virus- negative Hodgkin's lymphoma. Lancet. 2005; 365:2216-2224.
16. Mueller N, Evans A, Harris NL, et al. Hodgkin's disease and Epstein-Barr virus: altered antibody pattern before diagnosis. N Engl J Med. 1989;320:689-695.
17. Cartwright RA, Watkins G. Epidemiology of Hodgkin's disease: a review. Hematol Oncol. 2004;22:11-26.
18. Tomita Y, Ohsawa M, Kanno H, et al. Epstein-Barr virus in Hodgkin's disease patients in Japan. Cancer. 1996;77:186-192.
19. Weinreb M, Day PJ, Niggli F, et al. The role of Epstein-Barr virus in Hodgkin's disease from different geographical areas. Arch Dis Child. 1996;74:27-31.
20. Benharroch D, Shemer-Avni Y, Levy A, et al. New candidate virus in association with Hodgkin's disease. Leuk Lymphoma. 2003;44: 605-610.
21. Spina M, Berretta M, Tirelli U. Hodgkin's disease in HIV. Hematol Oncol Clin North Am. 2003;17:843-858.
22. Hansmann ML, Stein H, Fellbaum C, Hui PK, Parwaresch MR, Lennert K. Nodular paragranuloma can transform into high-grade malignant lymphoma of B type. Hum Pathol. 1989;20:1169-1175.
23. Stein H, Marafioti T, Foss HD, et al. Down-regulation of BOB.1/OBF.1 and Oct2 in classical Hodgkin disease but not in lymphocyte predominant Hodgkin disease correlates with immunoglobulin transcription. Blood. 2001;97:496-501.
24. Torlakovic E, Tierens A, Dang HD, Delabie J. The transcription factor PU.1, necessary for B-cell development is expressed in lymphocyte predominance, but not classical Hodgkin's disease. Am J Pathol. 2001;159:1807-1814.
25. Braeuninger A, Kuppers R, Strickler JG, Wacker HH, Rajewsky K, Hansmann ML. Hodgkin and Reed-Sternberg cells in lymphocyte predominant Hodgkin disease represent clonal populations of germinal center-derived tumor B cells. Proc Natl Acad Sci U S A. 1997; 94:9337-9342.
26. Marafioti T, Hummel M, Anagnostopoulos I, et al. Origin of nodular lymphocyte-predominant Hodgkin's disease from a clonal expansion of highly mutated germinal-center B cells. N Engl J Med. 1997;337:453-458.
27. Marafioti T, Hummel M, Foss HD, et al. Hodgkin and Reed-Sternberg cells represent an expansion of a single clone originating from a germinal center B-cell with functional immunoglobulin gene rearrangements but defective immunoglobulin transcription. Blood. 2000;95:1443-1450.
28. Kanzler H, Kuppers R, Hansmann ML, Rajewsky K. Hodgkin and Reed-Sternberg cells in Hodgkin's disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells. J Exp Med. 1996;184:1495-1505.
29. Thomas RK, Re D, Wolf J, Diehl V. Part I: Hodgkin's lymphoma-molecular biology of Hodgkin and Reed-Sternberg cells. Lancet Oncol. 2004;5:11-18.
30. Brauninger A, Hansmann ML, Strickler JG, et al. Identification of common germinal-center B-cell precursors in two patients with both Hodgkin's disease and non-Hodgkin's lymphoma. N Engl J Med. 1999;340:1239-1247.
31. Marafioti T, Hummel M, Anagnostopoulos I, Foss HD, Huhn D, Stein H. Classical Hodgkin's disease and follicular lymphoma originating from the same germinal center B cell. J Clin Oncol. 1999;17: 3804-3809.
32. Seitz V, Hummel M, Marafioti T, Anagnostopoulos I, Assaf C, Stein H. Detection of clonal T-cell receptor gamma-chain gene rearrangements in Reed-Sternberg cells of classic Hodgkin disease. Blood. 2000;95:3020-3024.
33. Diehl V, Sextro M, Franklin J, et al. Clinical presentation, course, and prognostic factors in lymphocyte-predominant Hodgkin's disease and lymphocyte-rich classical Hodgkin's disease: report from the European Task Force on Lymphoma Project on Lymphocyte-Predominant Hodgkin's Disease. J Clin Oncol. 1999;17:776-783.
34. Rowlings PA, Curtis RE, Passweg JR, et al. Increased incidence of Hodgkin's disease after allogeneic bone marrow transplantation. J Clin Oncol. 1999;17:3122-3127.
35. Kamel OW, Weiss LM, van de Rijn M, Colby TV, Kingma DW, Jaffe ES. Hodgkin's disease and lymphoproliferations resembling Hodgkin's disease in patients receiving long-term low-dose methotrexate therapy. Am J Surg Pathol. 1996;20:1279-1287.
36. Salloum E, Cooper DL, Howe G, et al. Spontaneous regression of lymphoproliferative disorders in patients treated with methotrexate for rheumatoid arthritis and other rheumatic diseases. J Clin Oncol. 1996;14:1943-1949.